Published on 10/28/2024 at 21:30, 2 hours 1 minute ago AI/ML Innovations Inc. Increases Proposed Private Placement
Published on 10/28/2024 at 21:05, 2 hours 26 minutes ago Armada Shareholders Approve Amalgamation For Going Private Transaction
Published on 10/28/2024 at 21:00, 2 hours 31 minutes ago Myriad Uranium Exercises Initial 50% Option On Rush's Copper Mountain Project
Published on 10/28/2024 at 19:15, 4 hours 16 minutes ago Tanvex CDMO to Exhibit at the 15th Annual World ADC Conference in San Diego
Published on 10/28/2024 at 18:00, 5 hours 31 minutes ago Sundance Institute and Gold House Announce Second Cohort of 'One House Filmmakers Fund', Made Possible With Funding From the East West Bank Foundation
Published on 10/28/2024 at 20:05, 3 hours 26 minutes ago EQS-Adhoc: Steyr Motors determines the placement price for the new shares
Published on 10/28/2024 at 19:12, 4 hours 18 minutes ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S adjusts outlook for the current financial year 2024/25
Published on 10/28/2024 at 19:00, 4 hours 31 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 21 OCTOBRE 2024 au 25 OCTOBRE 2024
Published on 10/28/2024 at 18:33, 4 hours 58 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 10/28/2024 at 18:28, 5 hours 2 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 10/28/2024 at 17:45, 5 hours 46 minutes ago Gimv participates in a $92M Series A financing round at Kivu Bioscience to advance next-gen antibody-drug conjugates
Published on 10/28/2024 at 17:45, 5 hours 46 minutes ago Gimv participates in a $92M Series A financing round at Kivu Bioscience to advance next-gen antibody-drug conjugates